PRMT5, as a tumor-promoting factor, is overexpressed in numerous cancers, including HCC, by participating in processes such as viral carcinogenesis, cell cycles, and spliceosome assembly [7,15,16,17,18]. This evidence concerns the gene PRMT5 and hepatocellular carcinoma.